Payment overview · 2025
General Payments
$31.97
1 reported records · 1 companies
Healthcare provider profile · identity verified
Miranda Dawn Panetta, ARNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · TAMPA, FL · NPI 1215332838
Verified facts
What the public records show
CMS Open Payments records show Miranda Dawn Panetta, ARNP received $31.97 in general payments during 2025 across 1 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $31.97 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $31.97 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $31.97 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Trazodone Hcl | Trazodone Hcl | 304 | 57 |
| Levothyroxine Sodium | Levothyroxine Sodium | 294 | 53 |
| Atorvastatin Calcium | Atorvastatin Calcium | 271 | 53 |
| Quetiapine Fumarate | Quetiapine Fumarate | 250 | 28 |
| Potassium Chloride | Potassium Chloride | 214 | 55 |
| Amlodipine Besylate | Amlodipine Besylate | 208 | 35 |
| Clonazepam | Clonazepam | 196 | 32 |
| Furosemide | Furosemide | 171 | 39 |
| Risperidone | Risperidone | 166 | 26 |
| Divalproex Sodium | Divalproex Sodium | 160 | 24 |
| Metformin Hcl | Metformin Hcl | 152 | 24 |
| Lisinopril | Lisinopril | 151 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 150 | 26 |
| Lactulose | Lactulose | 147 | 46 |
| Omeprazole | Omeprazole | 141 | 24 |
| Pantoprazole Sodium | Pantoprazole Sodium | 133 | 29 |
| Famotidine | Famotidine | 131 | 21 |
| Aripiprazole | Aripiprazole | 123 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 120 | 25 |
| Sertraline Hcl | Sertraline Hcl | 117 | 20 |
| Simvastatin | Simvastatin | 117 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 114 | 13 |
| Losartan Potassium | Losartan Potassium | 114 | 19 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 109 | 18 |
| Gabapentin | Gabapentin | 106 | 21 |
| Lorazepam | Lorazepam | 105 | 28 |
| Fluticasone Propionate | Fluticasone Propionate | 103 | 30 |
| Montelukast Sodium | Montelukast Sodium | 100 | 11 |
| Metoprolol Tartrate | Metoprolol Tartrate | 92 | 21 |
| Eliquis | Apixaban | 86 | 15 |
| Divalproex Sodium Er | Divalproex Sodium | 85 | 13 |
| Meloxicam | Meloxicam | 85 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 76 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 74 | 15 |
| Mirtazapine | Mirtazapine | 74 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 74 | 58 |
| Levetiracetam | Levetiracetam | 73 | 13 |
| Lamotrigine | Lamotrigine | 71 | 11 |
| Metoprolol Succinate | Metoprolol Succinate | 71 | 16 |
| Benztropine Mesylate | Benztropine Mesylate | 68 | 16 |
| Prazosin Hcl | Prazosin Hcl | 61 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 60 | suppressed |
| Alprazolam | Alprazolam | 56 | 12 |
| Carvedilol | Carvedilol | 56 | 12 |
| Ketoconazole | Ketoconazole | 53 | 22 |
| Memantine Hcl | Memantine Hcl | 53 | 14 |
| Buspirone Hcl | Buspirone Hcl | 50 | 15 |
| Tramadol Hcl | Tramadol Hcl | 50 | 24 |
| Amoxicillin | Amoxicillin | 49 | 44 |
| Clonidine Hcl | Clonidine Hcl | 48 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 48 | suppressed |
| Fenofibrate | Fenofibrate | 47 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 47 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 46 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 46 | suppressed |
| Glipizide | Glipizide | 45 | suppressed |
| Olanzapine | Olanzapine | 45 | 12 |
| Baclofen | Baclofen | 44 | suppressed |
| Pregabalin | Pregabalin | 44 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 42 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 41 | 17 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 41 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 41 | suppressed |
| Hydrocortisone | Hydrocortisone | 38 | suppressed |
| Sucralfate | Sucralfate | 38 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 37 | suppressed |
| Spironolactone | Spironolactone | 36 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Temazepam | Temazepam | 33 | 11 |
| Midodrine Hcl | Midodrine Hcl | 32 | suppressed |
| Xarelto | Rivaroxaban | 31 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 30 | suppressed |
| Mupirocin | Mupirocin | 28 | 17 |
| Farxiga | Dapagliflozin Propanediol | 26 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Bumetanide | Bumetanide | 25 | suppressed |
| Phenobarbital | Phenobarbital | 25 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Cephalexin | Cephalexin | 24 | 24 |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Norethindrone | Norethindrone | 24 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 20 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 23 | suppressed |
| Digoxin | Digoxin | 23 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 23 | suppressed |
| Hydroxyurea | Hydroxyurea | 23 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Paliperidone Er | Paliperidone | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Allopurinol | Allopurinol | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Guanfacine Hcl Er | Guanfacine Hcl | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Nystatin | Nystatin | 18 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Vascepa | Icosapent Ethyl | 17 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Finasteride | Finasteride | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | 15 |
| Prednisone | Prednisone | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | 11 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 14 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Valproic Acid | Valproic Acid | 14 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 13 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Constulose | Lactulose | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 13 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Azithromycin | Azithromycin | 12 | 12 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Drospirenone-Ethinyl Estradiol | Ethinyl Estradiol/Drospirenone | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $31.97 · 1 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error